Istalab 50/1000 Tablet is a carefully formulated medication that combines Sitagliptin Phosphate I.P. at a dosage of 50 mg and Metformin HCL I.P. at 1000 mg. This combination is specifically designed for the management of type 2 diabetes mellitus, providing a dual mechanism of action to help control blood glucose levels effectively. Sitagliptin, a DPP-4 inhibitor, enhances the body’s ability to regulate insulin secretion in response to meals, while Metformin, a biguanide, works primarily by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues.
The synergistic effect of these two active ingredients makes Istalab 50/1000 Tablet an effective option for patients who require comprehensive management of their diabetes. It is particularly beneficial for individuals who have not achieved adequate glycemic control with Metformin alone or those who are starting treatment for the first time. The combination therapy not only aids in lowering blood sugar levels but also helps in weight management, which is a significant concern for many patients with type 2 diabetes.
Patients taking Istalab 50/1000 Tablet may experience various side effects, although many individuals tolerate the medication well. Common side effects include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal discomfort. Some patients may also experience headaches or dizziness. In rare instances, more serious side effects can occur, including lactic acidosis, a rare but severe condition associated with Metformin. It is crucial for patients to be aware of these potential risks and to communicate any unusual symptoms to their healthcare provider.
For optimal storage, Istalab 50/1000 Tablet should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to store the medication out of reach of children and pets to prevent accidental ingestion.